Indian digital pathology market is growing at a CAGR of approximately 21.5% during the forecast period. India is providing significant opportunities in the healthcare sector and digital pathology market is expected to experience increase in demand of patient safety, precision in diagnostic and quality improvement which is emphasizing on development of technology and system which is highly specialized for pathology services. The conventional pathology may eliminate the inaccuracies in diagnostics which can adversely affect the patient health.
Visit for Global Digital Pathology Market Report at: https://www.omrglobal.com/industry-reports/digital-pathology-market
The American Recovery and Reinvestment Act of 2009 include a Title IV entitled (The Health Information Technology for Economic and Clinical Health Act) HITECH Act that informs about the healthcare and digitization efforts for future. Most of the institutions are taking initiatives for promoting the use of new pathology technology such as digital pathology, WSI, Telepathology which are primarily used for diagnostic and consultation of different patient cases with different healthcare experts within India or even throughout the world. The enhancement in field of biomedical informatics is a leading factor for the growth of digital pathology. There are several advantageous features offered by Indian digital pathology market such as utilization of digital images of high pixel for consultation as well as teaching purpose and the availability of images is easier compare to conventional.
Indian healthcare market is undergoing rapid change due to government and growth in healthcare sector which contributes to the Indian digital pathology market. E- Healthcare paved a way for digital pathology. As most of the private and public hospitals and multi super-specialty hospitals have integrated customized hospital management systems and other medical based IT services and products. Various key players in the market are adopting the e healthcare technology such as Apollo, AIIMS, among others. The healthcare system providers such Roche Diagnostics integrated pathology system introduced and installed at Anand Diagnostic in India. This system contains bot iScan Coreo scanner and the Virtuoso digital pathology software that will change the way of working in field of pathology. This technology is giving the immense benefits to the laboratories for making them operational efficient and productive.
Research Methodology
The market study of the Indian digital pathologymarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for digital pathology software, service and devices manufacturers, and other related companies for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Indian Digital Pathology Market Research and Analysis by Product and Services
2. Indian Digital Pathology Market Research and Analysis by End-user
3. Indian Digital Pathology Market Research and Analysis by Application
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Indian Digital Pathology Market by Products and Services
5.1.1. Diagnostic Devices
5.1.2. Scanners and Microscope
5.1.3. Communication Platform
5.1.4. Storage
5.1.5. Others
5.2. Indian Digital pathology Market by End-User
5.2.1. Biotechnology and Pharmaceutical Companies
5.2.2. Diagnostic Centers
5.2.3. Academics Centers
5.3. Indian Digital Pathology Market by Applications
5.3.1. Anatomical Pathology
5.3.2. Chemical Pathology
5.3.3. Forensic Pathology
5.3.4. Clinical Pathology
5.3.5. Immunopathology Pathology
5.3.6. Others
6. Company Profiles
6.1. BARCO
6.2. Carl Zeiss AG
6.3. Leica Microsystems GmbH
6.4. Nikon Instruments Inc.
6.5. Olympus Corp.
6.6. Philips Healthcare
6.7. Sysmex Corp.
1. INDIAN DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCTS AND SERVICES, 2018-2025 ($ MILLION)
2. INDIAN DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
3. INDIAN DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. INDIAN DIGITAL PATHOLOGY MARKET SHARE BY PRODUCTS AND SERVICES, 2018 VS 2025 (%)
2. INDIAN DIGITAL PATHOLOGY MARKET SHARE BY END-USER, 2018 VS 2025 (%)
3. INDIAN DIGITAL PATHOLOGY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)